Best Health Care Dividend Stocks Channel

Latest Articles

Featured

This Integrated Health Services Giant Was Just Reaffirmed — Is Its 8% Dividend Growth Rate the Real Story?

Shauvik Haldar | Jun 04, 2026

A vertically integrated health services company combining pharmacy benefit management and employer health insurance has been reaffirmed in our Best Health Care Dividend Stocks Portfolio.

Why This Health Services Giant Was Reaffirmed in Our Best Health Care Dividend Stocks Portfolio

Shauvik Haldar | Apr 01, 2026

A pharmacy benefits and employer health services company with a 2.34% forward yield, 8% 3-year dividend growth rate, and a rock-bottom beta of 0.23 earns its place among quality dividend holdings.

Reaffirming a Defensive Healthcare Leader in Our Best Healthcare Dividend Stocks Portfolio

Shauvik Haldar | Jan 29, 2026

A diversified healthcare giant offering innovative medicines for oncology and immunology alongside advanced medical devices continues to earn its place in our quality dividend portfolio.

Reaffirmed: This Healthcare Dividend Stock Balances Yield Safety and Growth Potential

Shauvik Haldar | Dec 03, 2025

Explore why this reaffirmed healthcare position offers a 1.87% forward yield with strong dividend safety, supported by low leverage and consistent growth.

Dividend Stability Reaffirmed as Growth Momentum Builds For Healthcare Pick

Shauvik Haldar | Oct 30, 2025

A leading healthcare name reaffirms its place in our quality dividend portfolio as steady device innovation and disciplined capital allocation continue to power long-term income potential.

Medical Technology Dividend Leader Maintains Its Place in the Quality Dividends Portfolio

Shauvik Haldar | Sep 04, 2025

This medical technology powerhouse remains a core holding in our Quality Dividends Portfolio. Explore what keeps it strong on dividend safety and risk stability despite growth challenges.

Reaffirmed: A Pharma Dividend Powerhouse You Can Count On

Shauvik Haldar | Jul 17, 2025

A leading pharmaceutical stock with decades of dividend growth just earned another Buy rating. Explore the factors driving its resilience and long-term appeal.

Our Take on This Medical Dividend Powerhouse: A Calculated Hold

Shauvik Haldar | Jun 17, 2025

We break down the strengths and limitations of this leading medical sector dividend stock. Consistent payouts, strong safety metrics—should you hold it too?

This Healthcare Dividend Powerhouse Just Got Reaffirmed — Here’s Why

Shauvik Haldar | May 07, 2025

See why we reaffirmed this healthcare sector dividend powerhouse in our portfolio. With market-leading scale, strong financials, and dividend strength, it’s a stock worth knowing.

A Must-Hold Medical Devices Stock With Bulletproof Dividend Credentials

Shauvik Haldar | Apr 02, 2025

Learn why this Medical Devices powerhouse—with rock-solid dividend safety and exceptional liquidity—continues to earn its spot in our premium portfolio.

A High-Yield Biotech Stock Built for Stability & Growth—Here’s Why It’s a Buy

Shauvik Haldar | Feb 11, 2025

This biotech giant boasts a strong dividend yield, decades of payouts, and low-risk stability. See why it remains a top choice for long-term investors.

Balancing Risk and Reward: How a Leading Health Care Facility Services Stock is Outperforming the S&P 500

Shauvik Haldar | Feb 28, 2024

Explore a well-covered large-cap Health Care stock with a low payout ratio, high 3Y Div CAGR, and strong YTD returns. Ideal for balanced dividend investors seeking portfolio diversification.

A Top Dividend Stock in the Medical Devices Industry: A Must-Have for Balanced Investors

Shauvik Haldar | Jan 17, 2024

Reaffirmed as a top holding in Best Sector Dividend Stocks portfolio, this large-cap Medical Devices stock boasts a 40+ year dividend increase track record. With a low beta and promising returns, it's ideal for balanced dividend investors.

Unveiling a Top-Performing Biotech/Pharma Stock with a Promising Dividend Yield and Payout Increase

Shauvik Haldar | Jan 10, 2024

Explore a well-covered mega-cap Biotech/Pharma stock with a good yield, 50+ year dividend increase track record, and low correlation to equity markets. Ideal for balanced dividend investors.

Unveiling a Top-Performing Health Care Facility Services Stock with Impressive Dividend Growth

Shauvik Haldar | Dec 21, 2023

Explore a new addition to the Best Health Care Dividend Stocks model portfolio. This large-cap stock offers a low payout ratio, high 3Y Div CAGR, and low beta.

Diversify Your Equity Portfolio with this Low-Beta, High-Yield Biotech/Pharma Stock

Shauvik Haldar | Dec 13, 2023

Explore our latest addition to the Best Sector Dividend Stocks model portfolio. A mega-cap Biotech/Pharma stock with a 60+ year dividend increase track record. Ideal for balanced dividend investors.

Investing in Health Care Dividends: Unveiling a Large-Cap Medical Devices Stock with Promising Returns

Shauvik Haldar | Dec 06, 2023

Explore our new addition to the Best Sector Dividend Stocks model portfolio - a well-covered large-cap Medical Devices stock with a 40+ year dividend increase track record.

Diversify Your Equity Portfolio with this Low-Risk, High-Yield Health Care Facility Services Stock

Shauvik Haldar | Nov 15, 2023

Explore the latest addition to our Best Sector Dividend Stocks model portfolio. This large-cap Health Care stock offers a low payout ratio, high 3-year dividend growth, and low market correlation.

Discover the Biotech/Pharma Stock with an Impressive 11-Year Dividend Increase Track Record

Shauvik Haldar | Nov 02, 2023

Explore our latest addition to the Best Sector Dividend Stocks model portfolio - a top-ranking, well-covered large-cap Biotech/Pharma stock with a strong dividend increase track record.

Why Balanced Dividend Investors Should Consider This Top-Performing Medical Devices Stock

Shauvik Haldar | Sep 21, 2023

Discover a top-performing Medical Devices stock with a 47-year dividend increase track record, low correlation to equity markets, and promising returns. Ideal for balanced dividend investors.

Diversify Your Equity Portfolio with this Low Beta, High Yield Biotech Stock

Shauvik Haldar | Sep 14, 2023

Explore a well-covered large-cap Biotech/Pharma stock with a good yield, low payout ratio, and an 8-year dividend increase track record. Ideal for balanced dividend investors seeking portfolio diversification.